The Association between Angiogenesis and Pathological Stage in Colon Adenocarcinoma Based on Immunohistochemical CD34 Staining

Authors

1 Assistant Professor, Department of Pathology, School of Medicine AND Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran

2 - Associate Professor, Department of Pathology, School of Medicine AND Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Assistant Professor, Department of Surgery, School of Medicine AND Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran

4 Department of Pathology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Background: Finding non-invasive methods in predicting pathological stage is important for more accurate
prognosis and treatment-related decision-making. In this study, using immunohistochemical CD34 staining, the
association between the rate of angiogenesis and tumor pathological stage was examined in colon adenocarcinoma.
Methods: In this comparative cross-sectional study, 60 cases with colon adenocarcinoma admitted to Afzalipour
hospital in Kerman, Iran, between 2014 and 2016, were enrolled. Appropriates Paraffin blocks of tumoral tissue
were selected, and the mean number of vessels was determined through CD34 staining. The groups were then
compared in terms of the pathological stage of individual cases.
Findings: The mean number of vessels was 25.2 ± 8.9, and the minimum and maximum were 11 and 44,
respectively. The mean number of young vessels in 12 patients (20%) was mild, in 29 patients (48.3%) was
moderate, and in 19 patients (31.7%) was severe category. ANOVA test demonstrated that the number of new
vessels was significantly lower in cases at lower stages.
Conclusion: Significant reverse association was observed between the rate of angiogenesis and pathological
stage. Therefore, the number of young vessels created in the tumor can probably be one of the predictors of
pathologic stage.

Keywords


Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease E-Book. Philadelphia, PA: Elsevier Health Sciences; 2020.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
Dancourt V, Faivre J. Epidemiology and screening of colorectal cancer. Rev Prat 2004; 54(2): 135-42. [In French].
Correa Lima MP, Gomes-da-Silva MH. Colorectal cancer: Lifestyle and dietary factors. Nutr Hosp 2005; 20(4): 235-41.
Manfredi MA, Jiang H, Borges LF, Deutsch AJ, Goldsmith JD, Lightdale JR. Good agreement between endoscopic findings and biopsy reports supports limited tissue sampling during pediatric colonoscopy. J Pediatr Gastroenterol Nutr 2014; 58(6): 773-8.
Mahmodlou R, Mohammadi P, Sepehrvand N. Colorectal cancer in northwestern iran. ISRN Gastroenterol 2012; 2012: 968560.
Chan TH, Goh KL. Appropriateness of colonoscopy using the ASGE guidelines: experience in a large Asian hospital. Chin J Dig Dis 2006; 7(1): 24-32.
Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett 2006; 240(1): 143-7.
Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003; 278(6): 4238-49.
Quesada AR, Munoz-Chapuli R, Medina MA. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 2006; 26(4): 483-530.
Shakiba Y, Mansouri K, Mostafaie A. Anti-angiogenic effect of soybean kunitz trypsin inhibitor on human umbilical vein endothelial cells. Fitoterapia 2007; 78(7-8): 587-9.
Yin L, Li J, Ma D, Li D, Sun Y. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies. Oncol Lett 2020; 19(5): 3558-66.
Lopez A, Harada K, Vasilakopoulou M, Shanbhag N, Ajani JA. Targeting angiogenesis in colorectal carcinoma. Drugs 2019; 79(1): 63-74.
Cartana ET, Gheonea DI, Cherciu IF, Streata I, Uscatu CD, Nicoli ER, et al. Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis. Endosc Ultrasound 2018; 7(3): 175-83.
Braha M, Chikman B, Habler L, Shapira Z, Vasyanovich S, Tolstov G, et al. Lymphocytic Infiltration as a Prognostic Factor in Patients with Colon Cancer. Int J Surg Pathol 2016; 24(1): 16-23.
Tarta C, Teixeira CR, Tanaka S, Haruma K, Chiele-Neto C, da Silva VD. Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion. Arq Gastroenterol 2002; 39(1): 32-8.
Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011; 10(6): 417-27.
Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011; 91(3): 1071-121.
De BK, Cauwenberghs S, Carmeliet P. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr Opin Genet Dev 2011; 21(1): 73-9.
Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473(7347): 298-307.
Banner BF, Whitehouse R, Baker SP, Swanson RS. Tumor angiogenesis in stage II colorectal carcinoma: association with survival. Am J Clin Pathol 1998; 109(6): 733-7.
Abdalla SA, Behzad F, Bsharah S, Kumar S, Amini SK, O'Dwyer ST, et al. Prognostic relevance of microvessel density in colorectal tumours. Oncol Rep 1999; 6(4): 839-42.
Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15(20): 6412-20.
Fox SH, Whalen GF, Sanders MM, Burleson JA, Jennings K, Kurtzman S, et al. Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 1998; 69(4): 230-4.
Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, et al. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 2000; 157(5): 1523-35.
Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996; 77(8 Suppl): 1722-8.
Toma SC, Uscatu CD, Ungureanu BS, Mirea CS, Dumitrescu T, Georgescu EF, et al. Correlations between CD34 Immunolabelled Blood Vessels and CD34 mRNA Expression in Colorectal Cancer. Curr Health Sci J 2018; 44(1): 60-3.